Literature DB >> 12118861

Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival.

Eva Pokorná1, Otto Schück, Stefan Vitko, Henrik Ekberg.   

Abstract

The objective of this study was to evaluate estimated and measured donor renal function in predicting graft function long-term and to identify donor criteria associated with nonacceptable graft prognosis. In 200 consecutive cadaver donors creatinine clearance was measured at explantation and estimated using the Cockcroft formula on admission serum creatinine. Graft function was evaluated in recipients (n = 387) by 24-h creatinine clearance regularly during 3 years after transplantation. Measured creatinine clearance correlated to some extent with long-term graft function, while Cockcroft estimation was slightly superior and similar to using donor age only. Kidneys from donors with intra-operative creatinine clearance < or = 55 mL/min (median 50 mL/min) produced acceptable recipient graft function of 48 mL/min at 3 years and 76% 3-year graft survival. Donor age > or =60 years resulted in clearance at 3 years of 29 mL/min and 78% 3-year graft survival; adding the criteria of admission Cockcroft < or =60 mL/min, graft function at 3 years (28 mL/min) and 3-year graft survival (76%) were similar. In conclusion, creatinine-based estimates of the functional capacity of the donor kidney, calculated or intra-operatively measured, do little to improve the ability of donor age alone to predict long-term allograft function after renal transplantation, and nonacceptable donors are not discriminated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118861     DOI: 10.1034/j.1600-6143.2002.20414.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  1 in total

1.  Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation.

Authors:  W N Nijboer; T A Schuurs; J Damman; H van Goor; V S Vaidya; J J Homan van der Heide; H G D Leuvenink; J V Bonventre; R J Ploeg
Journal:  Am J Transplant       Date:  2009-06-12       Impact factor: 8.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.